Omega-3 delivery expert Virun raises $2.1m to fund expansion plans

By Elaine WATSON

- Last updated on GMT

Related tags: Nutrition, Venture capital

Virun's technology enables firms to add long chain omega-3 fatty acids EPA and DHA to clear, shelf-stable beverages without affecting odor or taste and without the need for preservatives
Virun's technology enables firms to add long chain omega-3 fatty acids EPA and DHA to clear, shelf-stable beverages without affecting odor or taste and without the need for preservatives
Virun - the firm behind patented technology enabling it to add fat-soluble bioactives from omega-3s to CoQ10 to shelf stable clear beverages - has raised $2.1m from private equity firm Bluestem and private investors to fund its expansion.

Founded in 2003, the California-based biotech firm is best known for its drug delivery platform, which uses natural transferrin technology to deliver drugs with increased oral bioavailability.

In the food and beverage industry, however, it is best known for developing encapsulation technologies that allow for improved absorption of non-polar or fat-soluble bioactive ingredients such as omega-3a, CoQ10, vitamin D3 and resveratrol.  

Uniquely, the ingredients/excipients used to deliver these bioactives do not get into the blood, said the firm, which has attracted interest from a range of leading players in the food and beverage industry, notably Hormel Foods, which uses Virun’s technology in its FUXIONS range of ingredients, said the firm.

“Virun’s success can be attributed to its ability to partner and joint venture with a range of companies seeking differentiation in the health, energy and diet foods and beverages markets.”

 A more natural means of omega-3 delivery

Historically, firms trying to incorporate long-chain omega-3s - which are prone to oxidation - in beverages have had to add ingredients to mask off-flavors, refrigerate their products, add unwanted preservatives or use detergents to reduce particle size and deliver lower turbidity, Virun CEO Philip Bromley told us in June.

“FUXIONS allows the omega-3 to be absorbed without the excipient being significantly absorbed into the body which ultimately delivers a safe, non-toxic and more natural means of omega-3 delivery.”

Click here​ to read about Virun’s tie up with Hormel.

Related news

Show more

Related products

show more

DHA ORIGINS™: The sustainable potential of algae.

DHA ORIGINS™: The sustainable potential of algae.

Fermentalg | 22-Jun-2020 | Technical / White Paper

Consumers find out about nutritional quality by closely scrutinizing the labeling and list of ingredients (clean label). They are interested in the provenance...

Optimal Cardiovascular Health Requires Vitamin K2

Optimal Cardiovascular Health Requires Vitamin K2

NattoPharma USA, Inc. | 15-Jun-2020 | Technical / White Paper

In these trying times, general health and basic nutrition are more important than ever. New research now punctuates the importance of securing this healthy...

Learn About dicentra’s Clinical Trial Services

Learn About dicentra’s Clinical Trial Services

dicentra – CRO and regulatory consulting firm | 10-Jun-2020 | Product Brochure

Learn about our people, our location, and our technology to discover why dicentra CRO is the best choice for your next research needs.

Related suppliers

Follow us

Products

View more

Webinars